JPS6055068B2 - １−（３−ハロ−２−ピリジニル）ピペラジン - Google Patents

１−（３−ハロ−２−ピリジニル）ピペラジン

Info

Publication number
JPS6055068B2
JPS6055068B2 JP57088171A JP8817182A JPS6055068B2 JP S6055068 B2 JPS6055068 B2 JP S6055068B2 JP 57088171 A JP57088171 A JP 57088171A JP 8817182 A JP8817182 A JP 8817182A JP S6055068 B2 JPS6055068 B2 JP S6055068B2
Authority
JP
Japan
Prior art keywords
piperazine
pyridinyl
fluoro
acid
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57088171A
Other languages
English (en)
Japanese (ja)
Other versions
JPS584766A (ja
Inventor
ウオルフレツド・エス・サアリ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS584766A publication Critical patent/JPS584766A/ja
Publication of JPS6055068B2 publication Critical patent/JPS6055068B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP57088171A 1981-05-26 1982-05-26 １−（３−ハロ−２−ピリジニル）ピペラジン Expired JPS6055068B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26712081A 1981-05-26 1981-05-26
US267120 1981-05-26

Publications (2)

Publication Number Publication Date
JPS584766A JPS584766A (ja) 1983-01-11
JPS6055068B2 true JPS6055068B2 (ja) 1985-12-03

Family

ID=23017399

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57088171A Expired JPS6055068B2 (ja) 1981-05-26 1982-05-26 １−（３−ハロ−２−ピリジニル）ピペラジン

Country Status (17)

Country Link
EP (1) EP0065757B1 (enExample)
JP (1) JPS6055068B2 (enExample)
AT (1) ATE11134T1 (enExample)
AU (1) AU547319B2 (enExample)
CA (1) CA1214467A (enExample)
DE (1) DE3261827D1 (enExample)
DK (1) DK234282A (enExample)
ES (4) ES8306740A1 (enExample)
FI (1) FI821739A7 (enExample)
GR (1) GR76413B (enExample)
IE (1) IE53035B1 (enExample)
IL (1) IL65802A (enExample)
NO (1) NO821730L (enExample)
NZ (1) NZ200642A (enExample)
PH (1) PH18686A (enExample)
PT (1) PT74926B (enExample)
ZA (1) ZA823611B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH056685U (ja) * 1991-07-09 1993-01-29 株式会社ユアサコーポレーシヨン 電池の艤装構造

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7345096B2 (en) 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US20040152710A1 (en) * 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7419980B2 (en) 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7402698B2 (en) 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7531543B2 (en) 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7365076B2 (en) 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7524846B2 (en) 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7414052B2 (en) 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
CN101671297B (zh) * 2008-09-11 2012-05-09 上海药明康德新药开发有限公司 4-(3-碘-2-吡啶基)哌嗪类化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773951A (en) * 1972-12-21 1973-11-20 Miles Lab Method of treating depression with 1-(2-pyridyl)piperazine
US4078063A (en) * 1976-09-24 1978-03-07 Merck & Co., Inc. Piperazinylpyridines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH056685U (ja) * 1991-07-09 1993-01-29 株式会社ユアサコーポレーシヨン 電池の艤装構造

Also Published As

Publication number Publication date
ES8403476A1 (es) 1984-03-16
PT74926B (en) 1985-05-16
PT74926A (en) 1982-06-01
PH18686A (en) 1985-08-29
NZ200642A (en) 1984-11-09
AU8380282A (en) 1982-12-02
ES512533A0 (es) 1983-06-01
FI821739A7 (fi) 1982-11-27
DE3261827D1 (en) 1985-02-21
ES8403475A1 (es) 1984-03-16
JPS584766A (ja) 1983-01-11
AU547319B2 (en) 1985-10-17
DK234282A (da) 1982-11-27
IE821225L (en) 1982-11-26
ATE11134T1 (de) 1985-01-15
GR76413B (enExample) 1984-08-10
CA1214467A (en) 1986-11-25
ZA823611B (en) 1983-12-28
EP0065757B1 (en) 1985-01-09
IE53035B1 (en) 1988-05-11
EP0065757A1 (en) 1982-12-01
ES519855A0 (es) 1984-03-16
IL65802A (en) 1985-12-31
ES519856A0 (es) 1984-03-16
ES8306740A1 (es) 1983-06-01
ES8403477A1 (es) 1984-03-16
ES519854A0 (es) 1984-03-16
FI821739A0 (fi) 1982-05-17
NO821730L (no) 1982-11-29
IL65802A0 (en) 1982-08-31

Similar Documents

Publication Publication Date Title
AU701452B2 (en) Benzylpiperidines and piperazines as muscarinic antagonists
JPS6055068B2 (ja) １−（３−ハロ−２−ピリジニル）ピペラジン
CZ8398A3 (cs) Difenylmethylenpiperidinový derivát a farmaceutický prostředek s jeho obsahem
US20020025967A1 (en) N-alkylpiperdine analogs and uses thereof in treating addictions
IE63691B1 (en) Muscarinic receptor antagonists
EP1325912A1 (en) 2,2-diphenylbutanamide derivatives and medicines containing the same
KR100302216B1 (ko) 새로운니코틴산에스테르화합물및그제조방법
US4442103A (en) Treating sedation with 1-(3-substituted-2-pyridinyl) piperazines
JP5486008B2 (ja) １‐ブチル‐２‐ヒドロキシアラルキルピペラジン誘導体およびその抗鬱剤としての使用
US4456604A (en) 1-(3-Halo-2-pyridinyl) piperazine
EP1097924A1 (en) 4-hydroxy-4-phenylpiperidine derivatives having -opioid agonist activity and pharmaceuticals containing the same
IE44425B1 (en) N-(2,6-dihalophenyl)-thioureas,-isothioureas and -guanidines
CS274494B2 (en) Method of substituted styrene derivatives preparation
GB2249093A (en) Piperidine derivatives and their use in pharmaceutical compositions
US5472966A (en) Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines
CS217979B2 (en) Method of making the cycloalcanonoximether
US4506074A (en) 2-[2-Pyridinyloxy(thio or amino)methyl]-1H-imidazoles and derivatives
JPH037280A (ja) 新規ベンゾチオピラニルアミン
EP0724578A1 (en) Amine derivatives as calcium channel antagonists
US4381302A (en) (6aα,10aα,11aα)-2-(2-Pyridinyl)-1,3,4,6,6a,7,8,9,10,10a,11,11a-dodecahydro-2H-pyrazino]1,2-b]isoquinoline and derivatives
EP0223124B1 (en) Substituted aminosulfonyl 6-nitrobenzoic-esters or amides, processes for their preparation and pharmaceutical compositions containing them
EP0401779B1 (en) 4,5,5a,6-Tetrahydro-3H-isoxazolo (5,4,3-kl)acridines derivatives, a process for their preparation and their use as medicaments
EP0375536B1 (en) Derivatives of 1,7'-(imidazo-(1,2-a)pyridine) 5'-(6'H) ones and process for their preparation
CZ287729B6 (en) Aminoalkyl aminopyridine derivatives, process of their preparation and pharmaceutical preparation in which they are comprised
US6313141B1 (en) 2-aminoalkylaminoquinolines as dopamine D4 ligands